Navigation Links
FMC Corporation and Pronova BioPharma Announce Agreement To Develop New Alginate-Based Capsule Products
Date:12/14/2007

PHILADELPHIA, Dec. 14 /PRNewswire-FirstCall/ -- FMC Corporation (NYSE: FMC) and Pronova BioPharma ASA (OSE: PRON) today announced the companies have entered into a worldwide license and development agreement to develop products using a novel capsule technology developed by FMC. The alginate-based capsule technology is expected to significantly strengthen the product life-cycle management of Pronova BioPharma's products and has the potential for use both with Pronova BioPharma's current active pharmaceutical ingredient, marketed as Omacor in Europe and Lovaza in the United States, as well as in future products under development.

Under the terms of the agreement, FMC will apply its technology to Pronova BioPharma's products while Pronova BioPharma will be responsible for the clinical development and for securing regulatory approval. Pronova BioPharma plans to initiate clinical trials in early 2009 and launch of the new capsule is expected in 2010-2011.

FMC's novel proprietary capsule technology uses alginate, a marine plant- derived biopolymer, as the main component in the capsule shell. Alginate is gastro-resistant, providing an enteric release profile that delays release of the drug until passage from the stomach into the intestine. The technology also has the benefit of producing a seamless capsule with a significantly thinner shell wall, reducing the size of the capsule by approximately 25 percent. The enteric release profile and smaller capsule size are expected to result in increased patient compliance.

Commenting on the announcement, Tomas Settevik, Chief Executive Officer of Pronova BioPharma, said: "The new alginate capsule technology has the potential to deliver significant benefits for patients, as well as creating important patent life-extensions for Omacor/Lovaza and other products under development in our pipeline. We look forward to working with FMC in bringing the new capsule technology to market, which we anticipate taking
'/>"/>

SOURCE FMC Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNewswire...oday it is acquiring the assets of Hyland Seeds, a...o. The addition of Hyland Seeds will further expan...company anticipates the introduction of SmartStax...olerant Trait Technology in corn in 2012. The tran...
(Date:11/24/2009)..., SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD ... Trademark Office (PTO) has allowed the patent app...D technology. , NOD technology is a highl...oteins into bio-adhesive nano-particles to enable ...njections. NOD technology is a platform technology...
(Date:11/24/2009)... , Primary efficacy endpoint has been met for p...etrial cancer, , QUEBEC CITY, Nov. 24 /PRNews...AEZS ; TSX: AEZ) (the "Company"), a global biophar...d oncology, today announced positive efficacy data...peptide conjugate, AEZS-108 (formerly AN-152), in ...
(Date:11/24/2009)...N,Italy,November24/PRNewswire/--HealthRoboticstoda...withagroupofselected,investors.ThisrecentlyformedT...oboticsCanada,Inc.andwillmarket,install,andsupport...cludesthe,revolutionaryproductofferingsi.v.STATION...Inc.willalsoprovideassistanceonan"asneeded,basis"t...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
..., 2007, 11:30 a.m. ET -, REDWOOD CITY, Calif., Oc...conference call to discuss the company,s third,qua... a.m. PT) on Thursday,November 1, 2007. Russell Ho... the call. A press release announcing Maxygen,s th...earlier that same day at approximately,9:00 a.m. E...
...ct. 19 AMERIGROUP,Corporation (NYSE: AGP ) today...rld Markets 18th Annual Healthcare Conference on N...he Company,s presentation, which begins Monday,Nov...d on AMERIGROUP,s Web,site, http://www.amerigroup...e,available for 30 days, and can be accessed at th...
...19 BioWa, Inc. (BioWa) announced,today that it ha...,GlaxoSmithkline (GSK) with access to BioWa,s pate...velopment of antibody-dependent cellular,cytotoxic...nts GSK non-exclusive rights to research and devel...or an undisclosed number of,targets. In return, Bi...
Other Biology Technology:Maxygen Third Quarter 2007 Financial Results Conference Call Notice 2BioWa Announces Licensing of BioWa's POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development 2
(Date:11/26/2009)...of using recordings of birdsong to accurately meas...t time sound recordings from a microphone array ha... species, populations. Because the new technique, ...nal of Applied Ecology , will also work with whale...lity to monitor whale and dolphin numbers. , Dev...
(Date:11/25/2009)...nia Institute of Technology (Caltech) have uncover...n the fruit fly, Drosophila melanogaster . , Th...nship between the neurotransmitter dopamine and at... described in the December issue of the journal N...bout 20,000 neurons and has long been considered a...
(Date:11/25/2009)...he linchpin of the environment, where atmosphere, ...y students see soil as "just dirt" a place to gro... are challenged with the task of helping students ...f soil in the environment. , A collaborative pr...t University of Nebraska-Lincoln, Oregon State Uni...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 1First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 2First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 3Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients 10363 1Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients 10363 2Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 1Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 2Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 3
...archers are working toward a future in which each ...aling how oncologists should treat the cancer to o...annot predict which patients with prostate cancer ...ether some of these patients have an indolent dise...nts with colorectal cancer have surgery, but some,...
...e researchers, in partnership with Affymetrix, Inc...me Array ?that can improve citrus varieties and su...mine which genes are turned on in a tissue of citr...ontent and disease, for example ?the chip provides...existing problems and making improvements to the f...
...nex or Xanax? Or maybe Zantac? If you,re a health ...--mistakes can be fatal. , An estimated 1.3 millio...ch year from medication errors, and the U.S. Feder...educe the possibilities of these errors, such as a...ction of Narcan but received Norcuron and went int...
Other Biology News:AIDS-related cognitive impairment exists in two separate forms 2AIDS-related cognitive impairment exists in two separate forms 3AIDS-related cognitive impairment exists in two separate forms 4AIDS-related cognitive impairment exists in two separate forms 5AIDS-related cognitive impairment exists in two separate forms 6AIDS-related cognitive impairment exists in two separate forms 7UCR researchers design chip that can improve citrus varieties 2UCR researchers design chip that can improve citrus varieties 3Computer scientist sorts out confusable drug names 2
...-neo-FRT-loxP template is designed to allow kanam...tic cells, respectively. It combines a prokaryoti...tance in E.coli with a eukaryotic promoter (PGK)...n cells. The prokaryotic promoter gb2 is a slight...
pORF39-Hph from InvivoGen
...-neo-loxP template is designed to allow neomycin/k...ells. The loxP-PGK-gb2-neo-loxP template encodes ...nes a prokaryotic promoter (gb2) for expression of...promoter (PGK) for expression of neomycin resistan...
...he kit provides a simple and efficient means for i...ing annexin V magnetic beads (MagBeads). Annexin V...with high affinity for phosphatidylseri The Apopt...cient means for isolation of apoptotic cells or re...
Biology Products: